Rash: mild-to-moderate rash has been reported in clinical studies with efavirenz and usually resolves with continued therapy.
Efavirensiga läbi viidud kliiniliste uuringute ajal on tekkinud kerge kuni mõõdukas nahalööve, mis on tavaliselt lahenenud ravi ajal.